SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Orphan Drugs and Their Impact on Pharmaceutical Development · Study

ReviewOrphan Drugs and Their Impact on Pharmaceutical Development

Misty M. Attwood2018

Review2018

Orphan Drugs and Their Impact on Pharmaceutical Development

Misty M. Attwood · Mathias Rask‐Andersen · Helgi B. Schiöth

65 citations·0/0 files stored·Trends in Pharmacological Sciences

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Pharmaceutical industry and healthcare Pharmaceutical studies and practices

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 65 citations exist upstream.

References

2010How to improve R&D productivity: the pharmaceutical industry's grand challenge 2012Diagnosing the decline in pharmaceutical R&D efficiency 2011The productivity crisis in pharmaceutical R&D 2016Trends in clinical success rates 2008The State of Innovation in Drug Development 2011Pricing and reimbursement of orphan drugs: the need for more transparency 2012Pharmaceutical Research and Development: What Do We Get for All that Money?2013The economics of biosimilars.

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2017Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indicationsreview · 6 shared references 2021Approval success rates of drug candidates based on target, action, modality, application, and their combinationsarticle · 4 shared references 2021A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directionsreview · 3 shared references 2016Changing R&D models in research-based pharmaceutical companiesreview · 3 shared references 2016When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisisarticle · 3 shared references 2018Financialized Corporations in a National Innovation System: The U.S. Pharmaceutical Industryarticle · 3 shared references

Details

Year2018

Typereview

Published2018-05-17

VenueTrends in Pharmacological Sciences

ISSN-L0165-6147

Languageen

Citations65

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1016/j.tips.2018.03.003

openalex_workW2803429027

Links

Imported from OpenAlex (CC0) — nothing here is generated.